Clinical Trial Update: Efficacy of the Dose Regimen of Oral Vitamin D 50,000 IU in the Treatment of Vitamin D Deficiency [Phase 2]

View source ↗

Summary

This update reports efficacy outcomes from a Phase 2 trial evaluating high-dose oral Vitamin D (50,000 IU) for treating Vitamin D deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitamin Deficiency

Drugs mentioned

• Vitamin D3 (cholecalciferol) 50,000 IU (cholecalciferol)

Snippet

Sponsor: Hayat Pharmaceutical Co. PLC | Conditions: Vitamin D Deficiency | Phase 2 | Status: UNKNOWN